SEC Form SC 13G/A filed by The Carlyle Group Inc. (Amendment)

2/12/24 11:22:07 AM ET

Investment Managers

Finance

Get the next $CG alert in real time by email

SC 13G/A 1 CarlyleGroupIncCG.txt MS AMENDMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.2)* Carlyle Group Inc. ----------------------------------------------------- (Name of Issuer) Common Stock ----------------------------------------------------- (Title of Class of Securities) 14316J108 ----------------------------------------------------- (CUSIP Number) December 31, 2023 ----------------------------------------------------- (Date Of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1745 (3-06) CUSIP No.14316J108 13G Page 2 of 5 Pages -------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSON: I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: Morgan Stanley I.R.S. # 36-3145972 -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP: (a) [ ] (b) [ ] -------------------------------------------------------------------------------- 3. SEC USE ONLY: -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION: Delaware. -------------------------------------------------------------------------------- NUMBER OF 5. SOLE VOTING POWER: SHARES 0 BENEFICIALLY -------------------------------------------------------------- OWNED BY 6. SHARED VOTING POWER: EACH 7,806,004 REPORTING -------------------------------------------------------------- PERSON 7. SOLE DISPOSITIVE POWER: WITH: 0 -------------------------------------------------------------- 8. SHARED DISPOSITIVE POWER: 10,485,962 -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: 10,485,962 -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES: [ ] -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): 2.9% -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON: HC, CO -------------------------------------------------------------------------------- CUSIP No.14316J108 13G Page 3 of 5 Pages -------------------------------------------------------------------------------- Item 1. (a) Name of Issuer: Carlyle Group Inc. -------------------------------------------------------------- (b) Address of Issuer's Principal Executive Offices: C/O THE CARLYLE GROUP 1001 PENNSYLVANIA AVENUE, N.W. WASHINGTON DC 20004 UNITED STATES OF AMERICA -------------------------------------------------------------- Item 2. (a) Name of Person Filing: (1) Morgan Stanley -------------------------------------------------------------- (b) Address of Principal Business Office, or if None, Residence: (1) 1585 Broadway New York, NY 10036 -------------------------------------------------------------- (c) Citizenship: (1) Delaware. -------------------------------------------------------------- (d) Title of Class of Securities: Common Stock -------------------------------------------------------------- (e) CUSIP Number: 14316J108 -------------------------------------------------------------- Item 3. If this statement is filed pursuant to Sections 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [ ] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) [ ] An investment adviser in accordance with Sections 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with Section 240.13d-1(b)(1)(ii)(F); (g) [x] A parent holding company or control person in accordance with Section 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] A non-U.S. institution in accordance with section 240.13d-1(b)(1)(ii)(J); (k) [ ] Group, in accordance with sections 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with sections 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Not Applicable CUSIP No.14316J108 13G Page 4 of 5 Pages -------------------------------------------------------------------------------- Item 4. Ownership as of December 31, 2023.* (a) Amount beneficially owned: See the response(s) to Item 9 on the attached cover page(s). (b) Percent of Class: See the response(s) to Item 11 on the attached cover page(s). (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: See the response(s) to Item 5 on the attached cover page(s). (ii) Shared power to vote or to direct the vote: See the response(s) to Item 6 on the attached cover page(s). (iii) Sole power to dispose or to direct the disposition of: See the response(s) to Item 7 on the attached cover page(s). (iv) Shared power to dispose or to direct the disposition of: See the response(s) to Item 8 on the attached cover page(s). Item 5. Ownership of Five Percent or Less of a Class. (1) As of the date hereof, Morgan Stanley has ceased to be the beneficial owner of more than five percent of the class of securities. Item 6. Ownership of More Than Five Percent on Behalf of Another Person. Not Applicable Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on By the Parent Holding Company. Not Applicable Item 8. Identification and Classification of Members of the Group. Not Applicable Item 9. Notice of Dissolution of Group. Not Applicable Item 10. Certification. (1) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. * In Accordance with the Securities and Exchange Commission Release No. 34-39538 (January 12, 1998) (the "Release"), this filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by certain operating units (collectively, the "MS Reporting Units") of Morgan Stanley and its subsidiaries and affiliates (collectively, "MS"). This filing does not reflect securities, if any, beneficially owned by any operating units of MS whose ownership of securities is disaggregated from that of the MS Reporting Units in accordance with the Release. CUSIP No.14316J108 13G Page 5 of 5 Pages -------------------------------------------------------------------------------- Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 12, 2024 Signature: /s/ Christopher O'Hara -------------------------------------------------------------------- Name/Title: Christopher O'Hara/Authorized Signatory, Morgan Stanley -------------------------------------------------------------------- MORGAN STANLEY

Get the next $CG alert in real time by email

Recent Analyst Ratings for

$CG

Date	Price Target	Rating	Analyst
12/11/2025	$74.00	Buy	UBS
10/3/2025	$74.00	Outperform	BMO Capital Markets
7/10/2025	$65.00	Neutral → Buy	Citigroup
5/14/2025	$56.00	Hold → Buy	TD Cowen
3/19/2025		Outperform → Perform	Oppenheimer
1/3/2025	$60.00	Peer Perform → Outperform	Wolfe Research
9/12/2024	$42.00	Equal Weight	Wells Fargo
8/27/2024	$55.00	Buy	Redburn Atlantic

More analyst ratings

SEC Form SC 13G/A filed by The Carlyle Group Inc. (Amendment)

2/12/24 11:22:07 AM ET

$CG

Investment Managers

Finance

Get the next $CG alert in real time by email

Recent Analyst Ratings for

$CG

Date	Price Target	Rating	Analyst
12/11/2025	$74.00	Buy	UBS
10/3/2025	$74.00	Outperform	BMO Capital Markets
7/10/2025	$65.00	Neutral → Buy	Citigroup
5/14/2025	$56.00	Hold → Buy	TD Cowen
3/19/2025		Outperform → Perform	Oppenheimer
1/3/2025	$60.00	Peer Perform → Outperform	Wolfe Research
9/12/2024	$42.00	Equal Weight	Wells Fargo
8/27/2024	$55.00	Buy	Redburn Atlantic

More analyst ratings

SEC Form SC 13G/A filed by The Carlyle Group Inc. (Amendment)

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$CG

SEC Form SC 13G/A filed by The Carlyle Group Inc. (Amendment)

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$CG

$CG
Analyst Ratings

UBS resumed coverage on Carlyle Group with a new price target

BMO Capital Markets initiated coverage on Carlyle Group with a new price target

Carlyle Group upgraded by Citigroup with a new price target

$CG
Insider Trading

Large owner Carlyle Group Inc. disposed of 6,815,617 units of Class B Common Stock, sold $554,953,657 worth of shares (19,136,333 units at $29.00), disposed of 1,549,243 shares and converted options into 6,815,617 shares (SEC Form 4)

Chief Operating Officer Lobue Lindsay was granted 183,655 shares, increasing direct ownership by 39% to 660,500 units (SEC Form 4)

Chief Financial Officer Redett John C. was granted 550,965 shares, increasing direct ownership by 50% to 1,651,081 units (SEC Form 4)

$CG
SEC Filings

The Carlyle Group Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

SEC Form 13F-HR filed by The Carlyle Group Inc.

SEC Form 10-Q filed by The Carlyle Group Inc.

$CG
Press Releases

Resonetics® Expands Bioelectronics Implant Offering with Acquisition of Manufacturing Assets and Process IP from Med-Ally

Abingworth Announces Leadership Transition and Appointments

Vantage Group Holdings to be acquired by Howard Hughes Holdings

$CG
Leadership Updates

Abingworth Announces Leadership Transition and Appointments

Acentra Health Appoints President and Chief Operations Officer Meghan Harris to Its Board of Directors

Acentra Health Names Patty Obermaier as Chief Growth Officer

$CG
Financials

Vantage Group Holdings to be acquired by Howard Hughes Holdings

ARMADA Acquires Poseidon Industrial LLC, Expanding Its Solutions Offering to the U.S. Navy and Defense Support Capabilities

Carlyle Secured Lending, Inc. Announces Financial Results For Third Quarter Ended September 30, 2025, Declares Fourth Quarter 2025 Dividend of $0.40 Per Common Share

$CG
Large Ownership Changes

Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

SEC Form SC 13G/A filed by The Carlyle Group Inc. (Amendment)

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $CG

SEC Form SC 13G/A filed by The Carlyle Group Inc. (Amendment)

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $CG

$CG Analyst Ratings

UBS resumed coverage on Carlyle Group with a new price target

BMO Capital Markets initiated coverage on Carlyle Group with a new price target

Carlyle Group upgraded by Citigroup with a new price target

$CG Insider Trading

Large owner Carlyle Group Inc. disposed of 6,815,617 units of Class B Common Stock, sold $554,953,657 worth of shares (19,136,333 units at $29.00), disposed of 1,549,243 shares and converted options into 6,815,617 shares (SEC Form 4)

Chief Operating Officer Lobue Lindsay was granted 183,655 shares, increasing direct ownership by 39% to 660,500 units (SEC Form 4)

Chief Financial Officer Redett John C. was granted 550,965 shares, increasing direct ownership by 50% to 1,651,081 units (SEC Form 4)

$CG SEC Filings

The Carlyle Group Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

SEC Form 13F-HR filed by The Carlyle Group Inc.

SEC Form 10-Q filed by The Carlyle Group Inc.

$CG Press Releases

Resonetics® Expands Bioelectronics Implant Offering with Acquisition of Manufacturing Assets and Process IP from Med-Ally

Abingworth Announces Leadership Transition and Appointments

Vantage Group Holdings to be acquired by Howard Hughes Holdings

$CG Leadership Updates

Abingworth Announces Leadership Transition and Appointments

Acentra Health Appoints President and Chief Operations Officer Meghan Harris to Its Board of Directors

Acentra Health Names Patty Obermaier as Chief Growth Officer

$CG Financials

Vantage Group Holdings to be acquired by Howard Hughes Holdings

ARMADA Acquires Poseidon Industrial LLC, Expanding Its Solutions Offering to the U.S. Navy and Defense Support Capabilities

Carlyle Secured Lending, Inc. Announces Financial Results For Third Quarter Ended September 30, 2025, Declares Fourth Quarter 2025 Dividend of $0.40 Per Common Share

$CG Large Ownership Changes

Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

Recent Analyst Ratings for
$CG

Recent Analyst Ratings for
$CG

$CG
Analyst Ratings

$CG
Insider Trading

$CG
SEC Filings

$CG
Press Releases

$CG
Leadership Updates

$CG
Financials

$CG
Large Ownership Changes